|Product Name||Cat #||Size|
Anti-Cannabinoid Receptor 1 (extracellular) Antibody
|ACR-001||1 x 50 µl|
Anti-Cannabinoid Receptor 2 Antibody
|ACR-002||1 x 50 µl|
Anti-Human Cannabinoid Receptor 2 (extracellular) Antibody
|ACR-003||1 x 50 µl|
Anti-GPR65 (TDAG8) (extracellular) Antibody
|AGR-043||1 x 50 µl|
Anti-δ-Opioid Receptor (OPRD1) (extracellular) Antibody
|AOR-014||1 x 50 µl|
Anti-κ-Opioid Receptor (OPRK1) (extracellular) Antibody
|AOR-012||1 x 50 µl|
Anti-µ-Opioid Receptor (OPRM1) (extracellular) Antibody
|AOR-011||1 x 50 µl|
Anti-Nociceptin Receptor (OPRL1) Antibody
|AOR-015||1 x 50 µl|
- Lyophilized Powder Lyophilized Powder
This product is freeze dried. All water molecules have been removed.
- Antigen Incl. Control Antigen Included
This antibody is shipped with its antigen FREE of charge!
Alomone Labs is pleased to offer the GPCR Pain-Related Antibody Explorer Kit (#AK-545). The Explorer Kit contains GPCR pain-related antibodies, ideal for screening purposes.
Cannabinoids have been used in eastern medicine for many years as pain relievers.1 Δ9-tetrahydrocannabinol (THC), the major psychoactive compound in marijuana and hashish, has been shown to interact with two specific cannabinoid receptors: cannabinoid receptor 1 (CB1 Receptor or CB1R) and cannabinoid receptor 2 (CB2 Receptor or CB2R).2
All three classic opioid receptors mediate opioid-induced analgesia. Supraspinal analgesia is mainly mediated by the µ-opioid receptor, whereas µ-, δ-, and κ-receptors participate in the control of pain at the spinal level.3